We're adding 10 years to healthy human lifespan
We develop therapies that reverse age-related disease.
We go after the biology of aging.
In the US, about 90% of healthcare spending goes to chronic disease, and age is the biggest risk factor for most of it. We go after aging itself.
We study what goes wrong in aging cells and design drugs that prevent and reverse the diseases it causes, using tools like single-cell multi-omics, pooled perturbation screens, and targeted delivery.
We work on mechanisms where an intervention has already worked in mammals and there is a realistic path to a human drug.
We’re building a generational pharma company. We run a portfolio of programs rather than betting on one. Our culture values kindness, rigor, and versatility. We move fast, and we bring work like manufacturing in-house so each experiment teaches us more, sooner. We bet on scientists who want to maximize their impact.
